Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
Scientists at the forum warned of an increasingly volatile health landscape
India continues to face a major maternal nutrition challenge, with nearly 60% of women affected by anaemia and more than 70% experiencing calcium deficiency
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
Subscribe To Our Newsletter & Stay Updated
